Poor ovarian reserve
Poor ovarian reserve is a condition characterized by a decreased number of oocytes in a woman's ovaries, or a reduced quality of the remaining oocytes. This condition is often associated with infertility and early menopause.
Definition[edit | edit source]
Poor ovarian reserve is defined by the diminished potential of the ovaries to produce egg cells that are capable of fertilization resulting in a healthy and successful pregnancy. This condition is different from ovarian failure where the ovaries completely stop functioning before the natural age of menopause.
Causes[edit | edit source]
The causes of poor ovarian reserve can be many and varied. They include genetic disorders, certain medical treatments such as chemotherapy or radiation therapy, autoimmune diseases, and endometriosis. Age is also a significant factor, as the number and quality of oocytes naturally decrease as a woman gets older.
Diagnosis[edit | edit source]
The diagnosis of poor ovarian reserve is typically made based on a woman's age, her ovarian function, and the results of hormone tests. These tests often include measurements of follicle-stimulating hormone (FSH), estradiol, and anti-Müllerian hormone (AMH).
Treatment[edit | edit source]
Treatment for poor ovarian reserve is focused on addressing the underlying cause, if known, and improving the chances of pregnancy. This may involve fertility treatments such as in vitro fertilization (IVF) or ovarian stimulation. In some cases, donor eggs may be used.
Prognosis[edit | edit source]
The prognosis for women with poor ovarian reserve varies widely and depends on many factors, including the woman's age, the severity of the condition, and the success of treatment.
See also[edit | edit source]
This gynecology related article is a stub. You can help WikiMD by expanding it.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD